Presenter: Terese C. Hammond, MD; Program Director of Pulmonary and Critical Care, Kaweah Health Medical Center; Head of Inflammatory and Pulmonary Diseases, MiNK Therapeutics Additional information ...

VP-315 is a potential first-in-class oncolytic chemotherapeutic peptide immunotherapy administered directly into a tumor to induce immunogenic cell death and thereby unleashing a broad spectrum of ...

Additional information on the poster presentation including session location and timing details will be made available by ASGCT via the ASGCT Annual Meeting conference program website in mid-April.

There is increasing evidence that stress is a potent modulator of brain and cognitive function. Brief activation of physiological stress systems during learning can facilitate memory consolidation, ...

As PCMag's resident data journalist, I practically live in Microsoft Excel. I've learned that it's capable of far more than I ...

Six months after receiving a surprise rejection due to what the FDA called “lack of substantial evidence of effectiveness,” Capricor’s cell therapy deramiocel showed significant benefits in upper-limb ...

This postdoctoral researcher investigates immune fitness to predict patient outcomes and immunotherapy responses in blood cancers and solid tumors.